Insilico Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference

HONG KONG and NEW YORK, Jan. 6, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), an end-to-end artificial intelligence (AI)-driven drug discovery company, will virtually participate in the 40th Annual J.P. Morgan Healthcare Conference. Alex Zhavoronkov, Founder and Chief Executive…